Publication | Closed Access

2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial

Ocular DiseaseNeonatologyOphthalmologyRainbow Extension StudyLaser TherapyPediatricsMaternal HealthNewborn MedicinePediatric OphthalmologyMedicineLow Birthweight Infants